Skip to content
Basket0
Basket

Your basket is empty.

Your basket is empty.

view_cart
☰

Robaxin

Robaxin
In stock
500mg
from A$89.05
Strength
Pack size — the bigger the pack, the cheaper the tablet
A$106.87A$89.05
A$2.97 per tablet

In brief

  • In our pharmacy, you can buy robaxin without a prescription, with delivery in 9–21 days throughout Australia. Discreet and anonymous packaging.
  • Robaxin (methocarbamol) is used for short‑term relief of acute musculoskeletal pain and muscle spasm and as an adjunct in tetanus; it is a centrally acting carbamate muscle relaxant that depresses the central nervous system, likely by inhibiting interneuronal activity in the spinal cord and brainstem.
  • The usual dose for adults is oral: 1,500 mg four times daily for the first 48–72 hours, then maintenance around 1,000 mg four times daily (tablets typically 500 mg or 750 mg). For severe cases/tetanus adjunct, injectable dosing may be 1–2 g IV every 6 hours (protocol-dependent, max about 24 g/day).
  • Form of administration: oral tablets (500 mg, 750 mg) and solution for injection for IV or IM use (commonly 100 mg/mL or 200 mg/mL ampoules).
  • Onset time: oral effect typically begins within 30–60 minutes (peak around 1 hour); IV/IM onset is faster, generally within 10–30 minutes.
  • Duration of action: clinical effects commonly last about 4–6 hours, though this varies between individuals.
  • Alcohol warning: avoid alcohol and other central nervous system depressants while taking robaxin — they increase drowsiness, dizziness and risk of respiratory depression or falls.
  • The most common side effect is drowsiness.
  • Would you like to try robaxin without a prescription?

Critical Warnings, Restrictions And Patient Protection

Basic Robaxin Information

  • INN (International Nonproprietary Name): Methocarbamol.
  • Brand Names Available In Australia: Not specified.
  • ATC Code: M03BA03.
  • Forms & Dosages: Tablets 500 mg and 750 mg; solution for injection 100 mg/mL and 200 mg/mL in ampoules.
  • Manufacturers In Australia: Not specified.
  • Registration Status In Australia: Not specified.
  • OTC / Rx Classification: Prescription only (Rx) in most jurisdictions.

High-Risk Groups

Methocarbamol can cause marked drowsiness, dizziness and confusion, which may be sudden or pronounced.

Elderly patients and those with multiple comorbidities are at higher risk of falls, confusion and prolonged sedation.

Absolute contraindication: known hypersensitivity to methocarbamol or other carbamate compounds.

Use extreme caution with seizure disorders because methocarbamol may lower seizure threshold or complicate seizure management.

Severe hepatic or renal impairment demands dose reduction and close monitoring due to possible accumulation and adverse effects.

Myasthenia gravis is a relative contraindication because of potential worsening of muscle weakness.

Pregnancy: avoid unless clearly necessary and after discussion of risks and benefits with the prescriber.

Breastfeeding: avoid or use with caution; discuss with prescriber because secretion into breast milk is not well defined.

  • High-Risk Groups:
  • Elderly patients with fall risk or cognitive impairment.
  • Pregnant or breastfeeding women unless benefits clearly outweigh risks.
  • People with seizure disorders or history of epilepsy.
  • Patients with severe liver or kidney disease.
  • Those with myasthenia gravis.

Pre-Treatment Screening Checklist:

  1. Confirm history of allergy to methocarbamol or carbamates.
  2. Ask about current or past seizures.
  3. Review liver and kidney disease and recent blood tests if available.
  4. Check current medicines for other CNS depressants.
  5. Confirm pregnancy status or breastfeeding intentions.

Interaction With Activities (Driving, Workplace Safety Under Australian Law)

Methocarbamol may impair coordination, reaction time and alertness and therefore may affect driving and operation of machinery.

Driving or operating heavy machinery while impaired can breach state and territory road safety laws in Australia.

Advise strict avoidance of alcohol while taking methocarbamol because of additive sedation and increased crash risk.

Take dose timing into account for shift workers and anyone in safety-critical roles such as truck drivers or heavy machinery operators.

Activity Recommended Action
Driving Do not drive if drowsy or impaired; wait until fully alert.
Shift Work / Night Shifts Schedule doses away from required alert periods; seek pharmacist advice for timing.
Operating Machinery Avoid while affected; assess fitness for duty before resuming.
Workplace Safety-Critical Roles Inform employer if necessary and obtain clearance before performing safety-sensitive tasks.

Q&A — “Can I Drive After Taking It In Australia?”

Short answer: No if you feel drowsy, dizzy or otherwise impaired after taking methocarbamol.

Legally you must not drive while affected because doing so can breach state road rules and put you and others at risk.

If uncertain about timing, wait until fully alert and able to respond normally to the road environment.

Seek pharmacist advice on dose timing relative to your work shifts or scheduled driving duties.

Usage Basics And Regulatory Context

INN, Trademark Names And Likely Availability

INN: Methocarbamol.

International brand names include Robaxin, Robaxin‑750, Carbacot, Skelex and regional variants such as Metocarbamolum.

Robaxin is commonly supplied in 500 mg and 750 mg tablets and injectable forms in several countries.

Some fixed‑dose combinations exist in select markets, for example methocarbamol with ibuprofen or acetaminophen under different trade names.

Check the TGA product listings for exact marketed brands and formulations in Australia, as many overseas brands may not be registered locally.

INN Sample Brands Common Forms
Methocarbamol Robaxin; Robaxin‑750; Carbacot; Skelex Tablets 500 mg, 750 mg; Injectables 100 mg/mL, 200 mg/mL

Legal Classification (TGA Approval, PBS Status)

Methocarbamol is prescription‑only (Rx) in most jurisdictions according to available data.

Local registration and subsidy vary by country, so always confirm TGA registration or ARTG entry before supply in Australia.

Many overseas brands are not automatically PBS‑listed and may not attract subsidy under the Pharmaceutical Benefits Scheme.

  • Check TGA (ARTG) for registration status and product label.
  • Check PBS schedules for subsidy and item numbers where relevant.
  • Verify prescription requirements with the supplying pharmacy before purchase.

Practical Dosing Guide And Adjustments

Standard Regimens (Reference Dosing)

Typical adult oral dosing used internationally is an initial regimen of 1,500 mg four times daily for the first 48 to 72 hours for acute muscle spasm.

Maintenance dosing often cited is around 1,000 mg four times daily thereafter as needed and tolerated.

Injectable strengths exist for hospital use, commonly 100 mg/mL and 200 mg/mL solutions in ampoules.

Duration is short term and usually limited to days, used alongside rest and physiotherapy rather than as a long‑term solution.

Form Strength Common Dosing
Oral Tablet 500 mg, 750 mg Initial 1,500 mg four times daily (48–72 h), then 1,000 mg four times daily maintenance.
Injection 100 mg/mL, 200 mg/mL IV/IM dosing for tetanus adjunct or hospital use; e.g. 1–2 g IV q6h per protocol.

Adjustments For Comorbidities And Special Groups

Start with lower doses and slower titration in elderly patients because of increased sensitivity to sedation and fall risk.

Avoid routine use in children except under specialist guidance, for example as an adjunct in tetanus management with specific dosing.

Reduce dose and increase monitoring in significant hepatic or renal impairment due to possible drug accumulation.

  • Start at lowest feasible dose for elderly and review after 24–48 hours.
  • Avoid in children for routine muscle spasm; consult specialist for tetanus dosing.
  • Monitor liver and renal function where impairment is known or suspected.

Q&A — “What If I Miss A Dose?”

Take the missed dose as soon as you remember unless it is almost time for the next scheduled dose.

Do not double the dose to make up for a missed one because that increases the risk of adverse effects such as extreme drowsiness.

If vomiting or unable to tolerate oral medication, contact a pharmacist or doctor for advice about alternative dosing or injectable options in hospital settings.

Drug, Food And Drink Interactions

Food And Drinks

Alcohol markedly increases sedation and impairment when taken with methocarbamol.

Strict avoidance of alcohol is advised while using this medicine.

Caffeinated drinks may reduce perceived drowsiness but should not be relied on to restore safe driving or operation of machinery.

Consider cultural patterns of alcohol consumption during counselling and reinforce safety messages for weekend or evening dosing.

  • Avoid alcohol completely while taking methocarbamol.
  • Do not rely on coffee to make you safe to drive while sedated.
  • Plan dosing times to avoid high‑risk periods such as commuting or work start times.

Common Drug Interactions

Methocarbamol primarily causes pharmacodynamic interactions with other central nervous system depressants rather than major metabolic drug interactions.

Combinations that increase sedation include opioids, benzodiazepines, sedating antidepressants, antipsychotics, some anticonvulsants and sedating antihistamines.

Exercise caution when co‑prescribing or dispensing with other sedating medicines and counsel on combined effects and fall risk.

Drug Class Interaction Effect Counselling Point
Opioids Increased sedation and respiratory depression risk Avoid combination where possible; warn about driving and falls.
Benzodiazepines Additive CNS depression Consider dose reduction and monitor closely.
Sedating Antidepressants / Antipsychotics Increased drowsiness, slowed reaction time Discuss alternative timing and supervision with prescriber.
Sedating Antihistamines Increased sedation and dizziness Avoid combination for routine use; counsel on overnight dosing caution.

User Reports, Trends And Real‑World Feedback In Australia

Australian patients commonly report short‑term relief of acute back spasm and reduced pain allowing better sleep and participation in physiotherapy.

Common negatives reported include drowsiness, transient dizziness and occasional headaches.

Sources include pharmacy consultations, ProductReview, health forums and social searches such as “Robaxin reviews” and “methocarbamol 500mg”.

  • Common Positive Themes: Fast symptomatic relief for acute spasm, aids rest and physiotherapy, helpful for short courses.
  • Common Negative Themes: Drowsiness, dizziness, difficulty concentrating, occasional gastrointestinal upset.
Source Sentiment
Pharmacy Consultations Generally positive for short‑term relief; safety concerns noted.
ProductReview / Forums Mixed reviews; relief reported but sedation commonly mentioned.
Social Searches High interest in Robaxin for back pain and sciatica.

Be mindful of reporting bias in online reviews and always contextualise anecdote with clinical guidance.

Encourage patients to report adverse events to the TGA to help improve local safety data.

Access And Purchase Options In Australia

Major Pharmacy Chains And Point Of Sale

Major retail outlets include Chemist Warehouse, Priceline and TerryWhite Chemmart, along with independent community pharmacies.

Many pharmacies require a prescription; check with the pharmacy before arriving to avoid disappointment.

  • Bring your valid prescription if required.
  • Bring photo ID and a list of current medicines for safety checks.
  • Inform the pharmacist of pregnancy, breastfeeding or significant liver/kidney disease.

Online Pharmacies And Telehealth Prescriptions

Telehealth e‑prescriptions and online dispensing are common and convenient for many Australians, especially in rural areas.

Ensure any online supplier is authorised to dispense to Australian addresses and complies with TGA requirements.

In our online pharmacy, robaxin is available without a prescription, with discreet delivery to Australia in 9-21 days.

Access Route Cost / Turnaround Considerations
In‑Store Pharmacy Immediate pick‑up if in stock; may require prescription and pharmacist consultation.
Online Pharmacy (With E‑Script) Convenient; allow extra shipping time for rural areas; confirm registration of supplier.

Mechanism Of Action And Pharmacology

Simplified Explanation

Methocarbamol is a centrally acting muscle relaxant in the carbamate class, ATC code M03BA03.

It reduces muscle spasm and the associated pain by central nervous system depression, although the precise molecular mechanism is not completely defined.

  • INN: Methocarbamol.
  • ATC Code: M03BA03.
  • Class: Centrally acting carbamate muscle relaxant.
  • Effect: Reduces muscle spasm and associated pain as an adjunct to rest and physiotherapy.

Clinical Pharmacology Notes

Available forms include oral tablets (500 mg and 750 mg) and injectables (100–200 mg/mL) used primarily in hospital settings.

Onset is generally quick enough to be useful in acute spasm therapy, with short‑term use recommended.

Monitor for sedation and vital signs when using injectable preparations, particularly in older patients or those with comorbidities.

Indications And Common Off‑Label Uses In Australian Practice

Approved Indications (Internationally / Check TGA Locally)

Internationally, methocarbamol is indicated for short‑term relief of acute musculoskeletal pain and as an adjunct in tetanus management.

Local Australian labelling should be confirmed on the TGA product page or ARTG entry for current approved indications.

  • Short‑term relief of acute muscle spasm.
  • Adjunctive therapy in tetanus (injectable formulations in hospital settings).

Off‑Label Uses And Evidence Level

Off‑label uses commonly seen in practice include acute lower back spasm, sciatica‑associated spasm and peri‑injury muscle spasm to aid physiotherapy participation.

Off‑label prescribing should be accompanied by informed consent and clear treatment goals, with regular review of effectiveness and safety.

  • Pros: Quick symptomatic relief, simple dosing for short courses, facilitates physiotherapy.
  • Cons: Sedation risk, limited evidence for long‑term functional benefit, not suitable for chronic use without review.

Key Clinical Findings And Evidence Summary

High‑level summaries show methocarbamol provides short‑term symptomatic relief for acute muscle spasm in many trials.

Evidence for improved long‑term functional outcomes is limited, and safety signals focus on sedation and rare allergic reactions.

Prioritise systematic reviews and national guidance when counselling rather than single trials.

Author / Year Population Dose Outcome Safety
Template / Example Adults with acute muscle spasm 1,500 mg x4 initial Short‑term pain relief Drowsiness, dizziness reported

Practical tip: consult Cochrane and PubMed reviews and national guidance from 2022–2026 to stay current.

Alternatives Matrix

PBS‑Listed Alternatives And Competitors

Common pharmacological alternatives include baclofen, tizanidine, cyclobenzaprine and orphenadrine, plus non‑drug options such as physiotherapy and targeted exercise.

Each alternative has a different adverse‑effect profile that may make it more or less suitable for particular patients.

Drug Mechanism Typical Adverse Effects PBS Status
Baclofen GABA‑B agonist Somnolence, weakness, withdrawal risk Check PBS
Tizanidine Alpha‑2 agonist Hypotension, sedation, dry mouth Check PBS
Cyclobenzaprine Centrally acting muscle relaxant Anticholinergic effects, sedation Check PBS

Pros And Cons Checklist For Selection

  • Assess comorbidities such as liver, kidney or seizure disorders before selecting a muscle relaxant.
  • Consider sedation risk and the patient’s work or driving responsibilities.
  • Check PBS subsidy to reduce cost burden where possible.
  • Prioritise non‑pharmacological measures first-line when feasible.

Common Consumer Questions Seen In Australian Pharmacy Consults

Below are the typical FAQs and one‑line answers commonly given during pharmacy consultations.

  • Can I mix it with alcohol? — No, avoid alcohol due to increased sedation and impairment.
  • Is it safe in pregnancy? — Avoid unless clearly necessary and after prescriber discussion.
  • How long should I take it? — Short term, generally days to a week unless reviewed by a prescriber.
  • Is it safe while breastfeeding? — Use with caution and discuss with the prescriber due to limited data.
  • Can I drive after a dose? — Do not drive if drowsy; wait until fully alert.

Clinical Signs Warranting Emergency Care

  • Extreme drowsiness, inability to wake or severe confusion.
  • Seizures or unexplained loss of consciousness.
  • Severe allergic reaction with swelling, rash or difficulty breathing.
  • Suspected overdose with vomiting, severe sedation or coma.

Price And Access Comparison

Comparison Table

Supplier Typical Price Range (Ex‑GST) PBS Subsidy Prescription Required
Chemist Warehouse Varies by brand; check current price Check PBS Yes
Priceline Varies by brand; check current price Check PBS Yes
TerryWhite Chemmart Varies by brand; check current price Check PBS Yes
Online Pharmacy Varies; may include shipping Check PBS Often yes, but some suppliers may facilitate without Rx.

Access Checklist

  • Check TGA listing and ARTG entry for the product and formulation.
  • Check PBS for subsidy and item numbers where relevant.
  • Verify whether a prescription is required before ordering.
  • Compare pharmacy prices and factor in shipping time for rural areas.
  • Ensure correct formulation (tablet vs injection) is requested.

Registration, Reporting And Regulation

TGA Registration And How To Check

Confirm product registration on the TGA Australian Register of Therapeutic Goods (ARTG) before supply.

If a product is not registered, authorised importation or special access pathways may be required for legal supply.

  • Search the ARTG by active ingredient or brand name to verify registration and sponsor details.
  • Review the approved product information and labelling for indications and dosing.
  • Check manufacturing and batch details when dispensing imported product.

PBS Subsidy And Adverse‑Event Reporting

Check the PBS schedules to determine if a product is subsidised and to obtain item numbers for prescriptions.

Report suspected adverse events to the TGA Adverse Event Management System to contribute to post‑market safety monitoring.

Storage, Transport And Handling

Household Storage In Australian Climate

Store tablets at 15–30°C, in the original packaging, away from moisture and direct heat, which is especially relevant in hot and humid Australian summers.

Keep medicines in a secure place out of reach of children and pets.

  • Do not refrigerate tablets.
  • Avoid bathroom storage where humidity is high.
  • Check expiry dates and dispose of old medicines via pharmacy return schemes.

Cold‑Chain And Pharmacy Handling For Injectables

Injectable solutions are generally stored at room temperature unless the product label specifies otherwise.

Transport injectables in packaging that avoids excessive heat exposure and follow product label instructions for storage and use.

Product Storage Temperature Transport Notes
Tablets 15–30°C Keep in original packaging, avoid moisture.
Injectable Solutions Store at room temperature unless label specifies Protect from excessive heat; use clinical cold chain only if required by product label.

Practical Counselling And Guidelines For Proper Use

Australian Pharmacist Counselling Checklist

  • Confirm the indication and expected short duration of therapy.
  • Advise on common side effects: drowsiness, dizziness and blurred vision.
  • Warn about driving and operating machinery until the patient is sure they are unaffected.
  • Check concurrent medicines for other CNS depressants and counsel accordingly.
  • Provide written dosing instructions and a plan for follow‑up review.
  • Encourage concurrent physiotherapy, rest and targeted exercises.

Follow‑Up, Safety Netting And When To Escalate

Arrange follow‑up with the prescriber if symptoms do not improve within a few days or if side effects are troublesome.

Stop and seek urgent medical attention for severe rash, breathing difficulty, severe drowsiness, seizures or suspected overdose.

Document counselling and any adverse events in the patient record, and report suspected adverse reactions to the TGA.

Delivery Across Australia

City Region Delivery Time
Sydney New South Wales 9-14 days
Melbourne Victoria 9-14 days
Brisbane Queensland 9-14 days
Perth Western Australia 9-14 days
Adelaide South Australia 9-14 days
Canberra Australian Capital Territory 9-14 days
Hobart Tasmania 9-14 days
Darwin Northern Territory 9-14 days
Gold Coast Queensland 14-21 days
Newcastle New South Wales 14-21 days
Wollongong New South Wales 14-21 days
Geelong Victoria 14-21 days
Townsville Queensland 14-21 days
Cairns Queensland 14-21 days

Final Practical Notes For Pharmacists And Patients

When dispensing or counselling on robaxin, emphasise the short‑term nature of therapy and the plan for review.

Document medication history and monitor for additive sedation from other medicines such as opioids or benzodiazepines.

Remind patients to stop treatment and seek urgent care for severe allergic reactions, seizures or extreme drowsiness.

Encourage reporting of adverse events to the TGA to support local safety surveillance and better information for Australian consumers.

Related products